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SUMMARY
Cbfa2 (AML1) encodes the DNA-binding subunit of a
transcription factor in the small family of core-binding
factors (CBFs). Cbfa2 is required for the differentiation of
all definitive hematopoietic cells, but not for primitive
erythropoiesis. Here we show that Cbfa2 is expressed in
definitive hematopoietic progenitor cells, and in endothelial
cells in sites from which these hematopoietic cells are
thought to emerge. Endothelial cells expressing Cbfa2 are
in the yolk sac, the vitelline and umbilical arteries, and in

the ventral aspect of the dorsal aorta in the aorta/genital
ridge/mesonephros (AGM) region. Endothelial cells lining
the dorsal aspect of the aorta, and elsewhere in the embryo,
do not express Cbfa2. Cbfa2 appears to be required for
maintenance of Cbfa2 expression in the endothelium, and
for the formation of intra-aortic hematopoietic clusters
from the endothelium.

INTRODUCTION

required for normal vascular network formation, and for
definitive hematopoiesis (Dumont et al., 1994; Sato et al.,
1995; Takakura et al., 1998).
Definitive hematopoietic progenitors and stem cells have
been found in several distinct sites in the embryo, including the
yolk sac (Moore and Metcalf, 1970; Toles et al., 1989;
Weissman et al., 1977), the umbilical and vitelline arteries,
the para-aortic splanchnopleure and the aorta/genital ridge/
mesonephros (AGM) region (Dieterlen-Lièvre and Martin,
1981; Eren et al., 1987; Godin et al., 1995, 1993; Medvinsky
and Dzierzak, 1996; Medvinsky et al., 1993; Müller et al.,
1994; Ogawa et al., 1988; Tavian et al., 1996; Yoder et al.,
1997). Some of these hematopoietic cells have been found in
close association with endothelium. In humans, chicks and
mice, clusters of hematopoietic cells were found associated
with the endothelium on the ventral surface (floor) of the dorsal
aorta (Dieterlen-Lièvre and Martin, 1981; Garcia-Porrero et al.,
1995; Tavian et al., 1996). In the mouse, the clusters are found
at the developmental time when long-term repopulating
hematopoietic stem cells (LTR-HSCs) appear in the AGM
region (Medvinsky and Dzierzak, 1996). Histological pictures
have also shown clusters of hematopoietic cells budding from
the endothelium of the vitelline and umbilical arteries in 9.5
dpc–11.5 dpc mouse embryos (Garcia-Porrero et al., 1995;
Wood et al., 1997). Grafting experiments in chicks suggest that
endothelial cells and intra-aortic hematopoietic clusters that
populate the floor of the dorsal aorta share a common
hemangioblast precursor in the splanchnopleural mesoderm
(Pardanaud et al., 1996). More recent experiments suggest that
definitive hematopoietic cells differentiate directly from an

Hematopoietic cells differentiate from mesoderm during
embryogenesis, in close association with endothelial cells. In
the mouse, the first blood cells (primitive erythrocytes) and
endothelial cells differentiate from mesodermal masses in the
yolk sac at about 7.5 days post coitus (dpc) (Haar and
Ackerman, 1971; Moore and Metcalf, 1970). The concurrent
development of both lineages led to the hypothesis, many years
ago, that endothelial cells and hematopoietic cells share a
common precursor called the hemangioblast (Murray, 1932;
Sabin, 1920). A common origin of both lineages is further
supported by recent molecular and genetic analyses. For
example, several cell surface markers are common to
endothelial cells and hematopoietic progenitors, including
CD34, Flk-1 and TIE2 (Augustin et al., 1994; Takakura et al.,
1998). In addition, cells of both lineages can be cultured from
mouse embryonic stem cells from a common, transient
progenitor (Choi et al., 1998; Nishikawa et al., 1998a).
Mutations in several genes affect both hematopoietic and
endothelial cell development. Flk1 is required for the
development of primitive and definitive hematopoietic cells
and endothelial cells in the embryo, and is thought to be
required at the level of the hemangioblast (Shalaby et al., 1997,
1995). Disruption of Scl disrupts primitive and definitive
hematopoiesis, and perturbs angiogenesis in the yolk sac, but
does not impair the initial formation of endothelial cells (Robb
et al., 1995; Shivdasani et al., 1995; Visvader et al., 1998). The
cloche gene is also required for normal blood and endothelial
cell development (Stainier et al., 1995). The Tie2 gene is
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endothelial precursor. For example, Nishikawa et al. (1998b)
showed that lymphoid cells could be cultured in vitro from VEcadherin-positive endothelial cells isolated from the yolk sac
and caudal region of mouse embryos. Lineage tracing
experiments demonstrated that endothelial cells in the chick
aorta marked with low-density lipoproteins (LDL) coupled to
DiI give rise one day later to LDL-marked hematopoietic
clusters on the floor of the aorta (Jaffredo et al., 1998).
Cbfa2 and Cbfb encode two subunits of a core-binding factor
(CBF) that is required at an early stage in definitive
hematopoiesis. Cbfa2 encodes a DNA-binding CBFα subunit,
and Cbfb encodes the non-DNA binding CBFβ subunit.
Homozygous disruption of either Cbfa2 or Cbfb severely impairs
definitive hematopoiesis, but does not affect primitive
erythropoiesis or development of the yolk sac vasculature (Niki
et al., 1997; Okuda et al., 1996; Sasaki et al., 1996; Wang et al.,
1996a,b). Differentiation of all definitive hematopoietic lineages
is affected, suggesting that Cbfa2 and Cbfb are required at the
level of definitive hematopoietic progenitors and/or stem cells.
To determine precisely when during definitive hematopoiesis
Cbfa2 and Cbfb are required, we identified cells expressing
Cbfa2 in developing mouse embryos, and examined the fate of
these cells in Cbfa2-deficient embryos. We find that Cbfa2
expression marks a transient population of endothelial cells
populating the floor of the dorsal aorta in the AGM region, as
well as endothelial cells in other sites where definitive
hematopoietic cells are thought to emerge. Intra-aortic
hematopoietic clusters in the vitelline and umbilical arteries, and
on the floor of the dorsal aorta are absent in Cbfa2-deficient
mice. We hypothesize that Cbfa2 is required for the ‘budding’
of hematopoietic cells from hemogenic endothelium at these
sites. Cbfa2 also appears to be required for maintenance of
Cbfa2 expression in endothelial cells.

MATERIALS AND METHODS
Recombination constructs and targeting of ES cells
The targeting vector replaced a 10.0 kb fragment, including exons 7
and 8 of Cbfa2, with lacZ coding sequences, followed by the PGKneor
gene. Nucleotides 702-970 from the pSV-β-galactosidase vector
(Promega) were amplified by polymerase chain reaction (PCR), using
the primers (sense) 5′-AACTGCAGTCGATCCCGTCGTTTTACAACA-3′ and (antisense) 5′-GTAACCGTGCATCTGCCAGT-3′. The
PCR product was cleaved with PstI and Bsu36I, and subcloned along
with a Bsu36 I-BamHI fragment from the pSV-β-galactosidase vector,
containing the 3′ end of lacZ coding sequences plus the SV40 small
T antigen and poly(A) signals, into the targeting vector. The lacZ/neo
cassette was flanked by 5.6 and 3.7 kb of Cbfa2 homology upstream
and downstream, respectively. A thymidine kinase gene (tk) under the
regulation of the PGK promoter was incorporated at the 3′ end of the
homology region.
The targeting vector was linearized with NotI, electroporated into
J1 ES cells, and Cbfa2lz/+ F1 mice generated by standard protocols,
and as described previously (Li et al., 1992; Wang et al., 1996a,b).
Genotypes were determined by β-galactosidase activity, Southern
blot analysis of tail, embryo, or yolk sac DNA (Fig. 1B), or by
PCR analysis using primers specific for the lacZ gene (5′ACTGGCAGATGCACGGTTAC-3′ and 5′-GTGGCAACATGGAAATCGCTG-3′).
Cbfa2lz/+ female mice were crossed with Cbfa2rd/+ males (Wang et
al., 1996a) to generate Cbfa2lz/rd embryos. The Cbfa2lz allele was
identified by β-galactosidase activity, and the Cbfa2rd allele by PCR,

using a primer from within neo (5′-TCGCAGCGCATCGCCTTCA3′), in conjunction with a primer from intron 4 of Cbfa2 (5′AGTAGATAGGTATGAGTCCC-3′). The cross was designed so that
PCR detection of the Cbfa2rd allele was not complicated by maternal
contamination of fetal tissues.
Light microscopy
Embryos were dissected at various stages of gestation and processed
for β-galactosidase activity, as described by Miles et al. (Miles et al.,
1997). 8 µm sections of entire paraffin wax-embedded embryos were
prepared, and alternate slides were counterstained with hematoxylin
and eosin to facilitate tissue identification. Forty embryos from 6.5 to
10.5 dpc were analyzed.
Semi-thin sections from AGM regions were prepared by fixing 10.5
dpc Cbfa2+/+ and Cbfa2lz/rd embryos in 3% glutaraldehyde (GTA),
2% paraformaldehyde (PF), 2.5% dimethylsulfoxide (DMSO), and
0.1% CaCl2 buffered by 0.1 M sodium cacodylate (pH 7.4) for at least
3 hours at room temperature (RT). Samples were rinsed three times
in 0.1 M sodium cacodylate containing 0.05% CaCl2 and 0.3 M
sucrose at pH 7.4, a transverse cut was made 2-3 somites caudal to
the developing forelimbs, and the posterior portion of the embryo
(including the AGM region) was post-fixed in 2% OsO4 in 0.1 M
sodium cacodylate/0.05% CaCl2/0.3 M sucrose at pH 7.4 for 2 hours
at RT. Samples were dehydrated through a graded series of ethanols
and propylene oxide, and embedded in epon (LX112). Semi-thin
sections (0.5-0.7 µm) were prepared from similar areas in each block
and stained with ‘Epoxy Tissue Stain’ (toluidine blue and basic
fuschin; Electron Microscopy Sciences, Inc.).
Ultrastructure analysis
Embryos (10.5 dpc) were isolated in ice cold PBS and fixed for 2 hours
at RT in 2% PF/0.25% GTA in 0.1 M piperazine-N, N′-bis[2-ethanesulfonic acid] (PIPES) buffer. Embryos were washed in PBS, then
stained with 1 mg/ml Bluo-gal (Sigma) for 6 hours at 37°C. Samples
were rinsed in PBS, a transverse cut made 2-3 somites caudal to the
developing forelimbs, and the posterior portion of the embryo post-fixed
in 3% GTA, 2% PF, 2.5% dimethylsulfoxide (DMSO), 0.1% CaCl2
buffered by 0.1 M sodium cacodylate (pH 7.4) for at least 3 hours at
RT. Samples were rinsed three times in 0.1 M sodium cacodylate at pH
7.4, post-fixed in 2% OsO4, 0.1 M sodium cacodylate (pH 7.4),
embedded in epon (LX112), and 0.5-0.7 µm sections prepared as
described above. Semi-thin sections were lightly stained (15-30
seconds) with ‘Epoxy Tissue stain’. Thin sections (60-90 nm) were
prepared from each block, stained with 2% aqueous uranyl acetate (50
minutes), followed by Reynold’s lead citrate (8 minutes). All electron
micrographs were taken at 80 or 100 kV on a JEOL 100CX.
Methylcellulose colony forming assays
Fetal livers, vitelline and umbilical arteries/cords were dissected from
11.5 dpc embryos and digested in 0.1% collagenase (Sigma, C2674),
20% fetal calf serum (FCS) in PBS at 37°C for 1-2 hours. Cells were
washed with alpha minimum essential medium (GIBCO/BRL) and
plated in 35 mm suspension dishes in alpha medium containing 0.8%
methylcellulose, 30% FCS, 1% bovine serum albumin, 2 mM
glutamine, 0.1% 2-mercaptoethanol (Methocult; Stemcell
Technologies,
Vancouver).
Methylcellulose
medium
was
supplemented with 1.3% pokeweed mitogen-stimulated spleen cell
conditioned medium (Stemcell Technologies), 2 units/ml
erythropoietin (R&D Systems), 20 ng/ml IL-3 (R&D Systems), 50
ng/ml stem cell factor (SCF; R&D Systems), and 5 ng/ml granulocytemacrophage colony stimulating factor (GM-CSF; R&D Systems).
FACS analysis
Livers and AGM regions from 11.5 dpc embryos, and bone marrow
from adult mice were prepared and loaded with di-(β-Dgalactopyranoside) (FDG) as described by Sanchez et al. (Sanchez et
al., 1996). Phycoerythrin (PE)-conjugated antibodies to c-kit (2B8),
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Mac-1 (M1/70), PECAM-1 (MEC13.3), and CD44 (IM7) were
obtained from Pharmingen. PE-conjugated streptavidin (Pharmingen)
was used to detect both biotinylated CD34 antibody (RAM34,
Pharmingen) and a biotinylated anti-goat antibody (Vector
Laboratories), after primary incubation with goat-anti-mouse SCF
(G19, Santa Cruz Biotechnology, Inc.). FDG-loaded cells (1×105)
from individual embryos, or pooled aliquots of cells from embryos
with identical genotypes were stained with primary antibody,
incubated on ice for 20 minutes, and washed with PBS/FCS.
Secondary and tertiary incubations were performed when applicable,
as described above. Appropriate isotope controls were used in each
experiment. After the final wash, cells were resuspended in 500 µl
PBS/FCS. The fluorescence created by the β-galactosidase reaction
was detected on the FITC channel of a FACStar (Becton-Dickinson).
PE was detected on the FL2 channel. Triple
labeling of cells was performed using a CyChrome
(FL3)
conjugated
streptavidin
(Pharmingen) to detect biotinylated antibodies,
while PE-labeled c-kit and β-galactosidase
expression were detected as described above.

expression in yolk sac endoderm, and intense expression in
small numbers of endothelial cells in yolk sac capillaries, in
hematopoietic cells closely associated with yolk sac
endothelium, and in endothelial cells that appear to be budding
into the lumina of yolk sac capillaries (Fig. 2C). Cbfa2 is also
expressed in mesenchymal cells in the distal portion of the
allantois at 8.5 dpc, at the point where it joins the chorion (not
shown). The allantois was recently shown to be a source of
HSCs in birds (Caprioli et al., 1998). The allantois will form
the body stalk, which includes the umbilical artery, a site where
hematopoietic cells have also been seen histologically in mice
(Garcia-Porrero et al., 1995; Wood et al., 1997).
In the 8.5 dpc embryo proper, Cbfa2 is expressed in

RESULTS
Cbfa2 and Cbfb are required for definitive
hematopoiesis, indicating that both subunits
of the heterodimer are essential for function
in vivo. Since Cbfa2 expression appears to be
more temporally and spatially restricted than
that of Cbfb (Ogawa et al., 1993; Satake et al.,
1995; Simeone et al., 1995; Wang et al.,
1993), it should be the more accurate
indicator of where the active heterodimer is
located. We introduced a marker, the bacterial
lacZ gene, into the Cbfa2 locus by
homologous recombination. The targeting
vector replaced exons 7 and 8 of Cbfa2 with
lacZ coding sequences (Fig. 1A,B). The
splice acceptor site from exon 7 was
preserved, so that a CBFα2-β-galactosidase
fusion protein would be synthesized
containing the N-terminal 242 amino acids
from CBFα2 (Bae et al., 1993) (including its
DNA-binding domain) fused to βgalactosidase sequences. Nuclear localization
sequences from CBFα2 should be contained
within the fusion protein (Kanno et al., 1998),
and we found β-galactosidase activity
concentrated in the nucleus (Fig. 1C).
Cbfa2 expression in Cbfa2lz/+ embryos is
first seen at 7.5 dpc, at the neural plate stage
of development (Fig. 2A), in the endoderm
and some extraembryonic mesodermal cells
(not shown). At 8.0-8.5 dpc, Cbfa2
expression coalesces into a tight band
encircling the yolk sac (Fig. 2B). All newly
emerging primitive erythrocytes in the yolk
sac express Cbfa2 at 8.0 dpc (not shown), but
by 8.5 dpc, Cbfa2 expression declines
significantly (Fig. 2C), and disappears
entirely by 10.5 dpc (Fig. 3C) in all primitive
erythrocytes. The ring of Cbfa2 expression
remaining at 8.5 dpc consists of punctate

Fig. 1. Generation of the Cbfa2lz allele. (A) Targeting strategy used to replace exons 7
and 8 of the Cbfa2 gene with lacZ coding sequences. Probe A was used to screen for
homologous recombination events, and probe B to confirm the deletion of exon 7
sequences in Cbfa2lz/lz embryos. The expected size of the EcoRI restriction fragments
that hybridize with probe A, and the SpeI fragment that hybridizes with probe B are
indicated. Black regions indicate Cbfa2 coding sequences in exon 7 and within exon 8.
S, SalI; E, EcoRI; P, PstI; Sp, SpeI; N, NaeI. (B) Southern analysis of genomic DNA
from 11.5 dpc embryos. (C) Predominantly nuclear localization of β-galactosidase
activity in mouse embryo fibroblasts isolated from 12.5 dpc Cbfa2lz/+ embryos.
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endothelial cells of the vitelline artery, and in the ventral
portion (floor) of the paired dorsal aortae (Fig. 2D). The
vitelline artery is the caudal extension of the dorsal aorta at 8.5
dpc, connecting it to the yolk sac circulation (for a brief
description of the development of the arterial system in the
caudal region of the mouse embryo, see Garcia-Porrero et al.,
1995). Cbfa2 expression in the vitelline artery is restricted to
its intra-embryonic portion, and is not seen in the segment of
the artery that extends into the yolk sac.
Cbfa2 expression in 10.5 dpc embryos can be seen in the
vitelline and umbilical arteries, the fetal liver, the AGM region,
and in sites unrelated to hematopoiesis (Fig. 2E). In the
vitelline (Fig. 2F) and umbilical arteries (not shown), grapelike clusters of hematopoietic cells expressing Cbfa2 can be
seen closely associated with endothelial cells in the lumen. The
extraembryonic portion of these arteries from 10.5-11.5
dpc embryos gave rise to large, predominantly myeloid
or mixed lineage colonies in colony forming unit culture
(CFU-C) assays (Fig. 2G,H; Table 1).
Fetal livers from 10.5 dpc embryos express Cbfa2 in
the liver capsule mesoderm (Fig. 5A,B), and in
hematopoietic cells (Fig. 3A). Fluorescence activated
cell sorting (FACS) analysis demonstrates that CBFα2+
fetal liver and adult bone marrow cells express cell
surface markers associated with definitive hematopoietic
stem cells and early progenitors (Fig. 4A-C,G-I). In fetal
livers from 11.5 dpc embryos, 36% of the cells coexpress Cbfa2 and CD34. The latter is expressed on fetal
liver and bone marrow hematopoietic stem cells and
early progenitors (Andrews et al., 1992; Katz et al.,
1985; Krause et al., 1994) (Fig. 4A). 25% of fetal liver
cells express both c-kit and Cbfa2 (Fig. 4A). Sanchez et
al. (1996) showed that fetal liver LTR-HSCs reside
mainly in the c-kit+CD34+ population. 14% of fetal liver
Fig. 2. Cbfa2 expression during mouse development in
Cbfa2lz/+ embryos. (A) Cbfa2 expression in the
extraembryonic tissue of a 7.5 dpc embryo, at the neural plate
stage. (B) Cbfa2 expression in developing blood islands at 8.5
dpc. The negative embryo on the right is a Cbfa2+/+
littermate. (C) Detail of the yolk sac (8.5 dpc) showing Cbfa2
expression in endothelial cells, and in hematopoietic cells
closely associated with the endothelium (black arrows). Note
that primitive erythrocytes express only low levels of Cbfa2
(outlined arrows). Punctate staining is also seen in the yolk
sac endoderm (e). (D) Section of an 8.5 dpc embryo showing
Cbfa2 expression in vitelline artery endothelial cells (v),
ventral walls of the paired dorsal aortae (a), and yolk sac (y)
vessels. Note that Cbfa2 expression is in the intraembryonic
segment (open arrow), but not the extraembryonic segment
(black arrow) of the vitelline artery. (E) View of a 10.5 dpc
embryo showing Cbfa2 expression in the vitelline (v) and
umbilical (u) arteries, AGM region (agm), and fetal liver (fl).
Expression is also seen in the olfactory epithelium (o), spinal
ganglia (g), and maxillary processes (m). Expression in
external genitalia is not visible from this angle. (F) View of
the vitelline artery intra-abdominal segment (10.5 dpc) with a
hematopoietic cell cluster expressing Cbfa2.
(G,H) Cytocentrifuge preparations of myeloid (G) and mixed
lineage (H) colonies from in vitro cultures of umbilical
arteries from 11.5 dpc Cbfa2+/+ embryos, showing
neutrophils (n), macrophages (m), eosinophils (eo), and
enucleated erythrocytes (er) (Wright Giemsa stain).

cells at 11.5 dpc are in the c-kit+CD34+ population, and 9095% of c-kit+CD34+ cells express Cbfa2 (Fig. 4B).
Other cell surface antigens expressed on fetal liver and bone
marrow CBFα2+ cells include the cell surface form of stem cell
factor (SCF), which is expressed in many tissues, including
CD34+ endothelial cells (Fennie et al., 1995; Fleischman et al.,
1995; Matsui et al., 1990). 37% of fetal liver cells express both
Cbfa2 and SCF, and 64% of c-kit+SCF+ fetal liver cells express
Cbfa2 (Fig. 4C). CD44, a marker of definitive hematopoietic
progenitor cells, is expressed on 84% of CBFα2+ fetal liver
cells (Fig. 4C). Mac-1, which is expressed on macrophages,
granulocytes and some LTR-HSCs (Morrison et al., 1995;
Sanchez et al., 1996), is expressed on 17% of CBFα2+ cells
(Fig. 4C). 55% of CBFα2+ fetal liver cells express PECAM-1
(CD31), a marker on vascular endothelial cells and early
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hematopoietic precursor cells (Albelda et al., 1990; Watt et al.,
1993) (Fig. 4C).
Cbfa2 is expressed at 10.5 dpc in the ventral portion of the
dorsal aorta within the AGM region (Fig. 3A,B). The anterior
and posterior boundaries of Cbfa2 expression in the AGM
region coincide with the location of the mesonephros, but do
not extend in the rostral direction into the region flanked by
pronephros. Four discrete cell types in the AGM region express
Cbfa2: mesenchymal cells, endothelial cells, small numbers of
hematopoietic cells in the lumen (Fig. 3C), and a few cells in
the mesonephros (not shown). Almost all endothelial cells in
the floor of the dorsal aorta express Cbfa2, while very few
endothelial cells in the roof of the aorta express Cbfa2.
Cbfa2 expression in endothelial cells was confirmed by
ultrastructural analysis, using a β-galactosidase substrate
(Bluo-gal), the product of which forms an electron dense
precipitate that adheres to cell membranes (Weis et al., 1991)
(Fig. 3E). CBFα2+ cells in the floor of the dorsal aorta
participate in the formation of zonula occludens type
(tight) junctions to adjacent endothelial cells. Many
CBFα2+ endothelial cells in the floor of the aorta have
a very rounded appearance, and appear to be budding
into the lumen of the aorta. In multiple sections from six
embryos we failed to identify any endothelial cells in
mitosis, suggesting this region of the dorsal aorta may
expand via recruitment of cells from the surrounding
mesenchyme.
FACS analysis of cells isolated from the AGM region
of 11.5 dpc embryos shows that 10% of CBFα2+ cells
express CD34 (Fig. 4D), and approximately 27% of
CBFα2+ cells express c-kit. LTR-HSCs isolated from
the AGM region of 11 dpc embryos reside in the ckit+CD34+ population (Sanchez et al., 1996). Within the
c-kit+CD34+population, 35% express Cbfa2 (Fig. 4E).
Fig. 3. Detail of Cbfa2 expression in the AGM region.
(A) Section of a Cbfa2lz/+ embryo (10.5 dpc) showing Cbfa2
expression in the ventral wall of the dorsal aorta (a), and in
fetal liver hematopoietic cells (fl). (B) Cbfa2 expression in the
ventral para-aortic mesenchyme. (C) View of the dorsal aorta
ventrolateral wall showing Cbfa2 expression in some
endothelial cells (closed arrows), para-aortic mesenchyme
(open arrows), and circulating hematopoietic cells (c). Note
that most circulating blood cells (primitive erythrocytes) no
longer express Cbfa2. The few circulating Cbfa2-positive
cells presumably represent definitive hematopoietic
progenitors, and display blast-like features in sections
counterstained with hematoxylin and eosin (not shown).
(D) View of the dorsal aorta (a) rostral to its bifurcation into
iliac arteries, from a Cbfa2lz/+ embryo (14.5 dpc), showing
Cbfa2 expression confined to the para-aortic mesenchyme.
The rounded morphology of endothelial cells is caused by
muscle contraction following fixation. (E) Electron
photomicrograph of the dorsal aorta ventral wall of a
Cbfa2lz/+ embryo (10.5 dpc) showing the Bluo-gal reaction
product (thin dark precipitate) outlining many endothelial
cells (arrows), and some subendothelial cells (s). Endothelial
cells expressing Cbfa2 are connected to adjacent endothelial
cells (Cbfa2 positive and negative) by tight junctions
(asterisks, also see enlarged inset). Note the protrusion of
many Cbfa2-positive endothelial cells into the lumen (L), as
well as the underlying cystic separation in some (o),
suggesting progressive detachment from the aortic wall.

Emergence of LTR-HSCs from the AGM region peaks at
approximately 11 dpc in the mouse (Sanchez et al., 1996). We
examined AGM regions from 14.5 dpc Cbfa2lz/+ embryos to
determine whether Cbfa2 expression in endothelium persists at
later stages of development. Cbfa2 expression in the dorsal
aorta of 14.5 dpc embryos was found immediately rostral to
the bifurcation of the dorsal aorta into the iliac arteries. The
dorsal aorta elongates in the caudal direction as the embryo
grows, and Cbfa2 expression at all stages examined (8.5-14.5
dpc) appears to coincide with the actively growing caudal
portion of the aorta. Histological sections show that Cbfa2
expression in the vicinity of the dorsal aorta at 14.5 dpc is
restricted to mesenchymal cells (Fig. 3D). The endothelium,
which at this time is separated from the mesenchyme by a layer
of smooth muscle, does not express Cbfa2. No budding of
hematopoietic cells from the endothelium is apparent at 14.5
dpc. Cbfa2 expression in the umbilical cord of 17.5 dpc
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embryos was also confined to the mesenchyme (not shown).
Therefore, endothelial cells that express Cbfa2 appear only
transiently during development, coincident with the emergence
of definitive hematopoietic progenitor and stem cells.

Cbfa2 is required for the formation of intra-aortic
hematopoietic clusters
To pinpoint when during hematopoiesis Cbfa2 is required, we
crossed Cbfa2lz/+ mice with mice heterozygous for a
nonfunctional Cbfa2 allele that lacks exon 5 (Cbfa2rd/+) (Wang

et al., 1996a). Neither fetal livers nor the vitelline and umbilical
arteries from 11.5 dpc Cbfa2lz/rd embryos gave rise to definitive
hematopoietic colonies in CFU-C assays (Table 1). Therefore,
the Cbfa2lz allele, which lacks coding sequences for the
CBFα2 C terminus (including the transactivation domain
(Kanno et al., 1998)), is a non-functional allele. We compared
the histology of normal (Cbfa2lz/+) and Cbfa2-deficient
(Cbfa2lz/rd) embryos. All embryos contain only one copy of the
Cbfa2lz allele, thus β-galactosidase expression levels can be
directly compared.

Fig. 4. Surface antigens on Cbfa2-positive cells from the fetal liver and AGM region of 11.5 dpc mouse embryos. (A) Expression on fetal liver
cells. Data are presented as FACS dot plots, and percentages of cells in each quadrant are indicated. Isotype control antibodies (PE and Cy) and
FDG (FITC) substrate double staining are shown for fetal livers from Cbfa2+/+ littermates. Triple staining was performed with FDG (FITC) to
detect CBFα2-βgal expression, Cy-streptavidin to detect biotinylated antibodies to CD34 and SCF, and PE directly coupled to an anti-c-kit
antibody. Analysis was performed on 105 cells from pooled fetal livers isolated from Cbfa2lz/+ embryos, and data from one representative
sample is shown. The mean values (range in parentheses) of 5-12 independent samples are: c-kit+CBFα2-βgal+ 24.1% (18.6%-27.5%);
CD34+CBFα2-βgal+ 34.4% (33.1%-36.5%); SCF+CBFα2-βgal+ 35.0% (33.2%-36.4%). (B) Triple staining was performed on fetal liver cells
as described in A, and the c-kit+CD34+ and c-kit+SCF+ gated populations in the upper right quadrant analyzed for CBFα2-βgal expression. The
average number of c-kit+CD34+ cells was 12.8% (8.8%-16.5%), and c-kit+SCF+ cells was 16.7% (12.2%-20.6%). Percentages of CBFα2-βgalpositive cells within the c-kit+CD34+ and c-kit+SCF+ populations are indicated. (C) Isotype control antibodies (PE) and FDG (FITC) substrate
double staining are shown for pooled fetal livers from Cbfa2+/+ embryos. Mean values (range in parentheses) of 5-12 independently pooled
fetal liver samples from Cbfa2lz/+ embryos are: CD44+CBFα2-βgal+ 58.4% (55.3%-61.2%); Mac-1+CBFα2-βgal+ 9.5% (8.3%-10.6%);
PECAM-1+CBFα2-βgal+ 30.8% (18.0%-42.1%). (D) AGM cells. Experiments were performed as described in A. Mean percentages: ckit+CBFα2-βgal+ 2.5% (1.6%-3.7%); CD34+CBFα2-βgal+ 6.1% (4.6%-8.2%); SCF+CBFα2-βgal+ 8.8% (6.3%-11.3%). (E) Triple staining of
AGM cells, as described in B. The average number of c-kit+CD34+ cells was 5.9% (4.2%-8.0%), and of c-kit+SCF+ cells was 7.8% (6.5%10.0%). (F) AGM cells, as in C. Mean values (range in parentheses): CD44+CBFα2-βgal+ 2.4% (1.9%-2.9%); Mac-1+CBFα2-βgal+ 2.5%
(2.1%-3.1%); PECAM-1+CBFα2-βgal+ 3.4% (3.0%-4.0%). (G) Adult bone marrow cells. Experiments were performed as described in A.
Mean percentages: c-kit+CBFα2-βgal+ 7.6% (6.6%-9.6%); CD34+CBFα2-βgal+ 5.4% (4.2%-7.1%); SCF+CBFα2-βgal+ 22.9% (13.6%35.8%). (H) Triple staining of bone marrow cells, as described in B. The average number of c-kit+CD34+ cells was 2.3% (1.9%-2.7%), and of
c-kit+SCF+ cells was 3.7% (2.9%-5.4%). (I) Bone marrow cells, as in C. Mean values (range in parentheses): CD44+CBFα2-βgal+ 83.2%
(79.6%-86.5%); Mac-1+CBFα2-βgal+ 64.9% (53.9%-72.6%); PECAM-1+CBFα2-βgal+ 12.4% (11.6%-13.7%).
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Table 1. Colonies arising from fetal liver, vitelline artery and umbilical artery hematopoietic progenitors isolated from
11.5 dpc Cbfa2+/+ and Cbfa2lz/rd embryos
Fetal livers

Vitelline and umbilical arteries*

Colony number
per embryo‡

Genotype

Embryos
analyzed

E

M

Mix

Embryos
analyzed

Cbfa2+/+

4

105 (37)

373 (105)

248 (37)

9

Cbfa2lz/rd

10

0

0

0

5

Colony number
per embryo‡
Artery§

E¶

M

Mix

Umbilical
Vitelline
Umbilical
Vitelline

0
0
0
0

29 (10)
29 (15)
0
0

3 (2)
6 (5)
0
0

*The extraembryonic portions (between the yolk sac and embryo proper) of the vitelline and umbilical arteries, representing approximately 104 cells, were
dissected and analyzed.
‡Colonies (>30 cells in size) were scored on days 7-8 of incubation. E, erythroid colonies; M, myeloid colonies; Mix, erythroid-myeloid mixed colonies.
Average number of colonies per embryo is indicated, followed by standard deviation in parentheses.
§Umbilical artery and vitelline arteries were isolated from the same embryos.
¶Small numbers of erythroid colonies were seen in separate experiments from pooled 10.5 dpc and 11.5 dpc Cbfa2+/+ embryos (not shown).

Fetal livers of 10.5 dpc Cbfa2lz/rd embryos contain CBFα2+
mesenchymal cells, but no CBFα2+ hematopoietic cells (Fig.
5B). FACS analysis of 11.5 dpc Cbfa2lz/rd embryos indicates
severe depletion of CD44+ hematopoietic progenitors (Fig.
6A). Significant decreases are also seen in the proportions of
CBFα2+c-kit+, CBFα2+CD34+, CBFα2+SCF+, and
CBFα2+CD44+ fetal liver cells.
The absence of fetal liver hematopoiesis does not
appear to result from failure of definitive hematopoietic
cells to home properly to the fetal liver, since
hematopoietic cells expressing Cbfa2 are also
undetectable in circulating blood (not shown). Rather,
there appears to be a defect in the formation of intraaortic hematopoietic clusters. No clusters of
hematopoietic cells are present in the vitelline arteries
of 10.5 dpc Cbfa2lz/rd embryos (Fig. 5F). Furthermore,
both the numbers of endothelial cells expressing Cbfa2,
and the intensity of Cbfa2 expression in endothelial cells
is dramatically reduced in the vitelline (Fig. 5F) and
umbilical (not shown) arteries. This defect is not caused
by failure of CBFα2+ endothelial cells to migrate to
these arteries, since CBFα2+ endothelial cells are
present one day earlier, at 9.5 dpc (Fig. 5D). Cbfa2
expression in yolk sac endothelial cells is, however,
absent in 9.5 dpc Cbfa2lz/rd embryos, and no CBFα2+
hematopoietic cells are visible (Fig. 5H).
Significant defects are also observed in the AGM region
of Cbfa2 deficient embryos. At 9.5 dpc, endothelial cells
Fig. 5. Fate of CBFα2+ cells in Cbfa2-deficient embryos.
(A,B) Views of fetal livers from Cbfa2lz/+ (A) and Cbfa2lz/rd
(B) embryos (10.5 dpc) showing the presence (A) and absence
(B) of hematopoietic cells expressing Cbfa2 within the liver
sinusoids. Note the positive staining in the liver capsule
mesoderm in both embryos. (C,D) View of the vitelline arteries
from Cbfa2lz/+ (C) and Cbfa2lz/rd (D) embryos (9.5 dpc)
showing endothelial cell expression. (E,F) Detail of vitelline
arteries of Cbfa2lz/+ (E) and Cbfa2lz/rd (F) embryos (10.0 dpc),
showing strong Cbfa2 expression in both endothelial cells and
hematopoietic clusters (E), and minimal expression in
Cbfa2lz/rd embryos (F). (G,H) View of yolk sacs showing strong
Cbfa2 expression in endothelial and hematopoietic cells in
Cbfa2lz/+ embryos (G), and its absence in Cbfa2lz/rd embryos
(H) (9.5 dpc).

and para-aortic mesenchymal cells expressing Cbfa2 are
present in the floor of the dorsal aorta in both Cbfa2lz/+ and
Cbfa2lz/rd embryos (Fig. 7A,B). However, whereas by 10.5 dpc
Cbfa2 expression has intensified in endothelial cells of Cbfa2lz/+
embryos and hematopoietic cells are apparent, Cbfa2
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Fig. 6. Expression of hematopoietic markers in 11.5 dpc Cbfa2lz/+ and Cbfa2lz/rd embryos. (A) Fetal livers, analyzed as described in Fig. 4. Data
are from individual, representative embryos. The average values (range in parentheses) for 8-13 embryos of CBFα2-βgal+ cells expressing
other cell surface markers (upper right quadrants) are as follows: Cbfa2lz/+; c-kit+ 22.6% (19.1%-28.0%), CD34+ 42.0% (37.6%-47.6%), SCF+
40.3% (36.1%-40.9%), CD44+ 56.6% (55.1%-63.6%). Cbfa2lz/rd; c-kit+ 6.2% (4.8%-8.2), CD34+ 16.4% (14.5%-18.3%), SCF+ 13.6% (11.1%18.3), CD44+ 1.7% (0.8%-3.1%). The differences between Cbfa2lz/+ and Cbfa2lz/rd embryos in all double positive populations was significant at
t=0.01, as determined by a two tailed t-test. (B) AGM regions from individual embryos. Average values for CBFα2-βgal double positive cells
(upper right quadrants) are as follows: Cbfa2lz/+; c-kit+ 3.4% (1.2%-4.7%), CD34+ 8.9% (5.4%-15.1%), SCF+ 4.8% (2.2%-6.7%), CD44+ 3.5%
(1.8%-4.7%). Cbfa2lz/rd; c-kit+ 2.0% (1.1%-2.8%), CD34+ 8.2% (7.5%-9.8%), SCF+ 4.2% (3.5%-4.8%), CD44+ 1.6% (1.5%-2.0%).

expression fades significantly in endothelial cells of Cbfa2lz/rd
embryos (Fig. 7C,D). Endothelial cells in the floor of the dorsal
aorta in Cbfa2lz/rd embryos are relatively flat and elongated (Fig.
7H-I), compared with those in Cbfa2lz/+ embryos (Figs 7G, 3E).
There is also significant crowding of para-aortic mesenchymal
cells immediately adjacent to the ventral endothelium in
Cbfa2lz/rd embryos that is not seen in more dorsal sections of
the aorta, nor in Cbfa2lz/+ embryos (Fig. 7E,F and G-H). The
mesenchymal cells are elongated and flattened and in close

contact with the overlying endothelium (Fig. 7H,I), but do not
form desmosomes or junctional complexes with the
endothelium (not shown).
The numbers of CBFα2+c-kit+, CBFα2+CD34+,
CBFα2+SCF+, and CBFα2+CD44+ cells in AGM regions from
Cbfa2lz/+ and Cbfa2lz/rd embryos are not statistically different
(Fig. 6B). The presence of CBFα2+ cells in the AGM region
that express c-kit, CD34 and SCF suggests that Cbfa2 is not
required for the expression of these three cell surface markers.
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DISCUSSION
Cbfa2 is required for the differentiation of all definitive
hematopoietic cells, but not for primitive erythropoiesis. Here
we show that Cbfa2 is expressed in a small, transient
population of endothelial cells in the yolk sac, the
vitelline and umbilical arteries, and in the floor of the
dorsal aorta. Soon after Cbfa2 is expressed in these sites,
hematopoietic clusters appear that are closely associated
with Cbfa2-positive endothelium. The timing of Cbfa2
expression and appearance of intra-aortic hematopoietic
clusters parallels the emergence of definitive
hematopoietic cells, as detected previously by histology
and in vivo functional analyses (Garcia-Porrero et al.,
1995; Godin et al., 1995; Medvinsky and Dzierzak, 1996;
Müller et al., 1994). For example, definitive
hematopoietic progenitor cells with B-lymphoid potential
emerge autonomously at 8.5 dpc in mice, prior to the
establishment of embryonic circulation, both in the yolk
sac and the para-aortic splanchnopleure, the latter of
which includes the paired dorsal aortae and
intraembryonic portion of the vitelline artery (Godin et
al., 1995). The first long-term repopulating HSCs with
the potential to engraft irradiated adult recipients emerge
autonomously within the AGM region at 10.0 dpc.
(Medvinsky and Dzierzak, 1996; Müller et al., 1994).
Cbfa2 expression is apparent as early as 8.5 dpc in
endothelial cells lining the vitelline artery and in the floor
of the dorsal aortae. Cbfa2 expression in mesenchymal
cells at the distal tip of the allantois at 8.5 dpc precedes
Fig. 7. Defects in the AGM region of Cbfa2lz/rd embryos.
(A,B) Views of the dorsal aorta ventral wall showing
endothelial cell Cbfa2 expression in both Cbfa2lz/+ (A) and
Cbfa2lz/rd (B) embryos (9.5 dpc). (C,D) High power views of
the dorsal aorta ventral wall in Cbfa2lz/+ (C) and Cbfa2lz/rd
(D) embryos (10.0 dpc), showing Cbfa2 expression in the paraaortic mesenchyme in both embryos, endothelial cell
expression in the Cbfa2lz/+ embryo, and reduced endothelial
cell expression in the Cbfa2lz/rd embryo. (E,F) Comparative
semi-thin (0.6 µm) sections through the AGM regions of
Cbfa2+/+ (E) and Cbfa2lz/rd (F) embryos (10.5 dpc), showing
the relative cellular accumulation throughout the para-aortic
mesenchyme in Cbfa2lz/rd embryos (arrows) and the absence of
accumulation in Cbfa2+/+ embryos (see also G,H).
(G,H) Comparative high power views of the para-aortic AGM
regions of Cbfa2lz/+ and Cbfa2lz/rd embryos (10.5 dpc) showing
the Bluo-gal reaction product (dark blue precipitate on cell
membranes) in both endothelial and subendothelial cells. Note
the relatively flattened appearance of endothelial cells in
Cbfa2lz/rd embryos (H), most of which do not express Cbfa2,
as well as the subendothelial accumulation of Cbfa2-positive
cells throughout the para-aortic mesenchyme. Cells closer to
the coelomic epithelium (not shown) tend to orient their long
axes perpendicular to the endothelium (arrows), suggestive of
movement towards the aortic wall. In contrast, Cbfa2-positive
cells closer to the aortic wall orient their long axes parallel to
the endothelium, suggesting sub-endothelial accumulation.
(I) Electron micrograph of the region outlined in H showing
few positive cells in the aortic endothelium, the lack of
underlying cystic separation, and the concentration of paraaortic cells with their long axes parallel to the endothelium
(asterisks).

formation of the umbilical cord and later endothelial cell
expression at that site. Clearly demarcated regions of Cbfa2
expression are thus present as early as 8.5 dpc in all sites where
definitive hematopoietic cells later emerge, supporting the
hypothesis that definitive hematopoietic progenitors and/or
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stem cells emerge autonomously from distinct sites in the
embryo.

Cbfa2 appears to be required for budding of
hematopoietic cells from hemogenic endothelium
Jaffredo et al. (1998) recently showed that CD45− endothelial
cells in the chick embryo, labeled with DiI-coupled LDL, give
rise to LDL-labeled, CD45+ intra-aortic hematopoietic
clusters, demonstrating a precursor/progeny relationship
between endothelial cells and intra-aortic hematopoietic
clusters. Here we show that Cbfa2 is expressed in endothelial
cells prior to the emergence of intra-aortic hematopoietic cells
and clusters, and is required for the formation of these
hematopoietic cells. Taken together, the data suggest that
Cbfa2 is required for the budding of hematopoietic cells from
a definitive hemogenic endothelium. We envision that Cbfa2
acts as a molecular switch specifying the conversion from an
endothelial to hematopoietic cell fate.
Disruption of the Cbfa2 gene also impairs the maintenance
of Cbfa2 expression in endothelium. Endothelial cells
expressing Cbfa2 appear in the arteries of Cbfa2 deficient
embryos by 9.5 dpc, but a marked decline in Cbfa2
expression occurs soon thereafter. The reasons for this
decline are unclear. One possible explanation is that further
incorporation of CBFα2+ endothelial cells into these arteries
is impaired, which is suggested by the significant
accumulation of CBFα2+ para-aortic mesenchymal cells in
Cbfa2-deficient embryos. The dorsal aorta, vitelline and
umbilical arteries in Cbfa2-deficient embryos may continue
to expand via selective incorporation of CBFα2− cells,
thereby diluting out the contribution from CBFα2+ cells.
Another possibility is that the protein product of the Cbfa2
gene may positively regulate Cbfa2 expression. The human
Cbfa2 gene (CBFA2, or AML1) contains two promoters, one
of which has three potential CBF binding sites (Ghozi et al.,
1996). Cbfa2 may contain a promoter active in hemogenic
endothelial cells that initiates transcription of the gene.
Subsequent maintenance of Cbfa2 expression in hemogenic
endothelial cells, and stable commitment of these cells to the
hematopoietic lineage may require the active CBFα2:CBFβ
heterodimer.
Cbfa2 expression may mark cells derived from
definitive hemangioblasts in the splanchnopleural
mesoderm
Fate mapping studies in birds demonstrated that intra-aortic
hematopoietic clusters and endothelial cells that populate the
floor of the dorsal aorta differentiate from the
splanchnopleural
mesoderm,
presumably
from
hemangioblasts in the para-aortic mesenchyme (Pardanaud
and Dieterlen-Lièvre, 1993; Pardanaud et al., 1996, 1989).
Cells lining the roof of the aorta differentiate from
angioblasts in the somatopleural mesoderm committed to the
endothelial lineage. Cbfa2 is the first marker that
differentiates between endothelial cells in the roof and floor
of the dorsal aorta, and may specifically mark endothelial
cells and hematopoietic cells derived from putative
hemangioblasts in the splanchnopleural mesoderm. Many
cells in the ventral para-aortic mesenchyme also express
Cbfa2, some or all of which may be definitive
hemangioblasts.

The hemangioblast is most commonly described as a
mesenchymal precursor capable of differentiating directly into
either or both endothelial and hematopoietic cells. For
example, Choi et al. (1998) showed that nonadherent blast
colony-forming cells generated from mouse embryonic stem
cells could give rise to either or both endothelial cells and
hematopoietic progenitors, and suggested that the blast colonyforming cells are hemangioblasts. Eichmann et al. (1997)
demonstrated that Flk-1+ mesodermal cells isolated from the
posterior area of presomitic chick embryos could be
differentiated into Flk-1+ endothelial cells or Flk-1−
hematopoietic cells when cultured in vitro in the presence or
absence of vascular endothelial growth factor, respectively.
However, we and others (Garcia-Porrero et al., 1995; Jaffredo
et al., 1998) describe what appear to be newly emerging
hematopoietic cells in the dorsal aorta and vitelline arteries that
are connected via tight junctions to adjacent cells. These cells
form an integral part of the endothelium lining the lumen of
these arteries, and by this criterion are bona fide endothelial
cells, forming a hemogenic endothelium. Thus, we and others
(Jaffredo et al., 1998; Nishikawa et al., 1998b) propose that the
differentiation of at least some definitive hematopoietic
progenitors and/or stem cells from ‘definitive hemangioblasts’
appears to involve an endothelial intermediate. This process
may differ from that by which the first wave of primitive
erythrocytes and endothelial cells develop. Thus, the two views
of differentiation from the hemangioblast are not necessarily
incompatible.
The yolk sac gives rise to both primitive erythrocytes and
progenitors for definitive hematopoietic cells. Cbfa2 expression
in the primitive erythroid lineage is quite transient, and by 8.5
dpc has largely declined. Thereafter, Cbfa2 is expressed in a
punctate pattern in the yolk sac, in a small population of
endothelial cells, in hematopoietic cells in close contact with
the endothelium, and in hematopoietic cells that appear to be
budding from the endothelium. Young et al. (Young et al., 1995)
described a small population of CD34+ hematopoietic cells in
the yolk sac in close contact with the endothelium, although
details of hematopoietic budding would have been difficult to
see since all yolk sac endothelial cells express CD34. In Cbfa2deficient embryos, the first burst of Cbfa2 expression and
development of primitive erythrocytes from the extraembryonic
mesodermal mass occurs normally, but the subsequent budding
of hematopoietic cells from endothelial cells lining yolk sac
capillaries is impaired. We propose that at least some definitive
hematopoietic progenitors in the yolk sac may differentiate via
an endothelial cell intermediate in yolk sac capillaries, by a
process similar to that observed in the vitelline and umbilical
arteries and in the AGM region.
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